Credit score: Pixabay/CC0 Public Area
US shopper items large Kimberly-Clark introduced Monday a $48.7 billion deal to accumulate the most important well being firm Kenvue, whose Tylenol painkiller has confronted Trump administration allegations of hyperlinks to elevated autism dangers.
Texas-based Kimberly-Clark makes a variety of paper and material merchandise, with manufacturers comparable to Huggies, Kleenex and Kotex.
Kenvue, along with Tylenol, owns a broad array of shopper well being manufacturers, from Neutrogena and Listerine, to Band-Support.
“We are excited to bring together two iconic companies to create a global health and wellness leader,” Kimberly-Clark chief govt Mike Hsu stated in a press release.
The deal is predicted to shut within the second half of 2026, the businesses stated, with Hsu to develop into chairman and CEO of the mixed group.
The businesses count on the mixed entity to create 2025 annual web revenues of $32 billion.
Kenvue has not too long ago been within the highlight after allegations by President Donald Trump and his administration that acetaminophen, the lively ingredient in Tylenol, could also be linked to elevated threat of autism when utilized by pregnant ladies and newborns.
Medical teams have lengthy cited acetaminophen, also referred to as paracetamol, as a secure choice for lowering fever and ache throughout being pregnant.
Republican-led Texas filed swimsuit in opposition to Kenvue and Johnson & Johnson final week over the allegations.
Kenvue was spun off from Johnson & Johnson’s shopper items model in 2023.
© 2025 AFP
Quotation:
Kimberly-Clark to purchase Tylenol proprietor Kenvue in $48.7 bn deal (2025, November 3)
retrieved 3 November 2025
from https://medicalxpress.com/information/2025-11-kimberly-clark-buy-tylenol-owner.html
This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
